Escherichia Coli Bacteria
-
{
- All
- News
-
Study Says Cranberry Juice Can Help Antibiotics Fight Urinary Infections
The study tested "lab-grown" strains of Escherichia coli (E. coli), the most common germ behind UTIs, and found that adding cranberry juice improved the effect of a drug called fosfomycin in many cases.
-
Plastic To Paracetamol: Scientists Convert Waste Into Painkiller In 24 Hours
Scientists at the University of Edinburgh have developed a process using E. coli bacteria to convert PET plastic waste into paracetamol, offering a sustainable alternative to traditional drug manufacturing methods that rely on fossil fuels.
-
Researchers Find Second 'Superbug' Gene In US Patient
Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.
-
New anthrax vaccine from India
A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...
-
Study Says Cranberry Juice Can Help Antibiotics Fight Urinary Infections
The study tested "lab-grown" strains of Escherichia coli (E. coli), the most common germ behind UTIs, and found that adding cranberry juice improved the effect of a drug called fosfomycin in many cases.
-
Plastic To Paracetamol: Scientists Convert Waste Into Painkiller In 24 Hours
Scientists at the University of Edinburgh have developed a process using E. coli bacteria to convert PET plastic waste into paracetamol, offering a sustainable alternative to traditional drug manufacturing methods that rely on fossil fuels.
-
Researchers Find Second 'Superbug' Gene In US Patient
Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.
-
New anthrax vaccine from India
A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...
